Source: European Medicines Agency (EU) Publisher: Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Nadroparin calcium Aspen 15,200 I.U. anti-Xa/0.8ml double strength solution for injection in a pre-filled syringe.
| Pharmaceutical Form |
|---|
|
Solution for injection in pre-filled syringe. The solution is sterile and clear, pH 4.5 to 7.5. |
1 Pre-filled syringe with 0.8 ml solution for injection contains 15,200 I.U. anti-Xa nadroparin calcium derived from porcine intestinal mucosa.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nadroparin |
Nadroparin is a low-molecular weight heparin. Nadroparin inhibits Factor Xa in particular and thrombin to a lesser extent. Inhibition is partially mediated via the plasma protease inhibitor antithrombin III. Nadroparin has less effect on platelet function and aggregation and only has a minor effect on primary haemostasis compared to heparin. |
| List of Excipients |
|---|
|
Calcium hydroxide |
The prefilled syringe consists of a Type-I glass cylinder with stainless steel needle and needle guard made of natural and/or styrene-butadiene-rubber, a safety cylinder made of polypropylene and a piston with sealing lip made of butyl elastomer.
Packs with 2, 6, 10, 20, 30 and 50 graduated prefilled syringes, each containing 0.8 ml injection solution (0.8 ml injection solution contains 15,200 I.U. anti-Xa nadroparin calcium).
Not all pack sizes may be marketed.
Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
